Labiotech.eu
2,647 FOLLOWERS
Labiotech.eu is the leading digital media covering the European Biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Labiotech.eu
9h ago
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
The post Are new treatments for multiple sclerosis on the horizon? appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more
Labiotech.eu
2d ago
Explore Denmark's dynamic biotech scene with 9 innovative companies at the forefront of the biopharmaceutical revolution!
The post 9 biotech companies leading the way in Denmark appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more
Labiotech.eu
2d ago
Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success.
The post Large molecule manufacturing: addressing challenges with strategies for success appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the or ..read more
Labiotech.eu
3d ago
Discover how Novo Nordisk's new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy.
The post Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better? appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the or ..read more
Labiotech.eu
6d ago
Discover the pinnacle of biotechnology education in the UK with our article to the top universities offering cutting-edge programs.
The post 6 biotechnology universities in the UK leading the way for future talent appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original co ..read more
Labiotech.eu
6d ago
Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.
The post New treatments being developed for schizophrenia appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more
Labiotech.eu
1w ago
Explore the latest insights from France Biotech's 'Panorama France HealthTech' report, uncovering key insights of the French biotech sector.
The post Biotech in France: What’s holding back progress and how to move forward? appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the or ..read more
Labiotech.eu
1w ago
Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic.
The post Eight CAR-T cell therapy companies you should know about appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more
Labiotech.eu
1w ago
As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field.
The post Are molecular glues the key to undruggable targets? appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more
Labiotech.eu
1w ago
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
The post Is biotechnology a good career? Here are the pros and cons appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more